Skip to main content
Erschienen in: Journal of Medical Case Reports 1/2021

Open Access 01.12.2021 | Case report

Giant cell arteritis with cervical radiculopathy mimicking polymyalgia rheumatica and elderly-onset rheumatoid arthritis: a case report

verfasst von: Akihiko Nakabayashi, Hiroki Ikai, Yoshinori Katada

Erschienen in: Journal of Medical Case Reports | Ausgabe 1/2021

Abstract

Background

Giant cell arteritis has a wide variety of clinical symptoms, one of them being cervical radiculopathy, which mainly involves the C5 nerve root. If the patient does not develop typical clinical symptoms of giant cell arteritis but has C5 radiculopathy, it may be misdiagnosed as polymyalgia rheumatica or elderly-onset rheumatoid arthritis due to old age, high serum inflammatory markers, and difficulty in raising both upper limbs.

Case presentation

A 72-year-old Japanese man with a month-long history of dyspnea on exertion and with difficulty in raising both upper limbs was referred to our hospital because of elevated serum C-reactive protein (12.62 mg/dL). He had no typical symptoms of giant cell arteritis such as headache, jaw claudication, visual loss, and fever. The patient tested negative for rheumatoid factor and anti-cyclic citrullinated peptide antibody, and matrix metalloproteinase-3 was within the normal range (54.3 ng/mL). Musculoskeletal ultrasound examination showed absence of tenosynovitis, bursitis, and synovitis, and the patient did not meet the classification criteria of polymyalgia rheumatica or rheumatoid arthritis; hence, those two diseases were unlikely. A precise neurological examination suggested bilateral C5 and C6 anterior radiculopathy and left C4 radiculopathy. Since cervical magnetic resonance imaging showed no mechanical causality, cervical radiculopathy of unknown origin was suggested. Fluorodeoxyglucose positron emission tomography/computed tomography revealed increased fluorodeoxyglucose lineal uptake along the vessel walls, including temporal arteries, vertebral arteries, and axillary arteries. Results of the biopsy of the left superficial temporal artery were compatible with giant cell arteritis. He was successfully treated with 30 mg of prednisolone, and both upper limbs could be elevated.

Conclusions

If the patient was misdiagnosed with polymyalgia rheumatica or elderly-onset rheumatoid arthritis based on only clinical symptoms and laboratory data, his symptoms might not improve due to insufficient steroid dose and vascular complications may occur later. Although rare, peripheral neuropathy in giant cell arteritis may include cervical radiculopathy. The musculoskeletal ultrasound and precise neurological examination were the turning points for the diagnosis of this case, and making a careful diagnosis using these methods was important.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s13256-021-03107-7.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
GCA
Giant cell arteritis
PMR
Polymyalgia rheumatica
EORA
Elderly-onset rheumatoid arthritis
CRP
C-reactive protein
ESR
Erythrocyte sedimentation rate
RF
Rheumatoid factor
ACPA
Anti-cyclic citrullinated peptide antibody
MMP-3
Matrix metalloproteinase-3
18F-FDG PET/CT
Fluorodeoxyglucose positron emission tomography/computed tomography
PSL
Prednisolone

Background

Giant cell arteritis (GCA) is a chronic systemic vasculitis that occurs in people older than 50 years and generally affects large- and medium-sized arteries. GCA has a wide variety of symptoms such as headache, jaw claudication, visual loss, and systemic manifestations (anorexia, asthenia, malaise, myalgia, arthralgia, weight loss, and so on), but neurological symptoms may also occur [1]. GCA neuropathy is divided into central and peripheral neuropathy, and peripheral neuropathy occurs at a frequency of 1.1–14% [24]. However, radiculopathy is extremely rare in GCA patients with neuropathy [5]. Preferential involvement of the C5 nerve roots is also reported in GCA patients with radiculopathy [5, 6]. Because the deltoid, pectoralis major, and supraspinatus muscles are innervated by the C5 nerve, it is difficult to raise both upper limbs when this nerve is affected. Therefore, if the patient has no typical clinical symptoms of GCA but has C5 radiculopathy, it may be misdiagnosed as polymyalgia rheumatica (PMR) or elderly-onset rheumatoid arthritis (EORA) due to old age, high serum inflammatory markers, and difficulty in raising both upper limbs.
Herein, we report a case of GCA with cervical radiculopathy presenting clinical symptoms similar to those of PMR or EORA, whose diagnostic turning point was musculoskeletal ultrasound examination and precise neurological examination.

Case presentation

A 72-year-old Japanese man with a month-long history of dyspnea on exertion and bilateral shoulder pain gradually presented difficulty in raising both upper limbs. He visited a local doctor and underwent laboratory testing, which revealed an elevated serum C-reactive protein (CRP) (12.62 mg/dL). Hence, he was admitted to our hospital. He was naturally healthy and had no allergies, therefore was not on any medication. He is currently unemployed. His sister has a medical history of rheumatoid arthritis, and his daughter has a medical history of systemic lupus erythematosus. He has smoked 40 cigarettes a day for the past 50 years and does not consume alcohol. On admission, his vital signs were as follows: blood pressure 147/90 mmHg, pulse 110 beats/minute, respiratory rate 12 breaths/minute, and SpO2 98% (room air). He had no headache, jaw claudication, visual loss, or fever. Tenderness in the bilateral temporal arteries was absent, whereas mild tenderness was observed in both shoulders. The upper right limb could not be elevated to shoulder level, whereas the upper left limb could not be elevated at all (Fig. 1a). A physical examination revealed no abnormalities other than those mentioned above. The laboratory tests revealed an increase in CRP and erythrocyte sedimentation rate (ESR) levels (13.99 mg/dL and 31 mm/hour, respectively). Both rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) were negative, and the matrix metalloproteinase-3 (MMP-3) level remained normal (54.3 ng/mL). Antinuclear antibody and anti-SSA antibody were also negative (Table 1). PMR and EORA were considered as differential diagnoses. However, PMR was unlikely as there were no signs of tenosynovitis and bursitis in both shoulders on musculoskeletal ultrasound examination. Moreover, the total score was 3 points and did not meet the 2012 Provisional Classification Criteria for Polymyalgia Rheumatica (“absence of RF or ACPA”: 2 points, “absence of other joint involvement”: 1 point; Table 2) [7]. EORA was also unlikely because both RF and ACPA were negative, and there were no signs of synovitis on musculoskeletal ultrasound examination. Moreover, the total score was 2 points and did not meet the 2010 Rheumatoid arthritis classification criteria (“joint involvement”: 1 point, “acute-phase reactants”: 1 point; Table 3) [8]. Since he did not complain of pain even if both upper limbs were passively lifted, neurological disease or muscle disease was considered. Precise neurological examination revealed that there was absence of sensory impairment, but deep tendon reflexes were present in bilateral triceps and the lower limbs, except for bilateral biceps and brachioradialis reflexes. Muscle strength was evaluated by conducting a manual muscle test. The muscle strength of the biceps brachii, brachioradialis, supinator teres, deltoid, pectoralis major, supraspinatus, and infraspinatus decreased predominantly on the left side (Table 4). Ultrasonographic examination showed absence of movement in the left diaphragm during breathing. Hence, bilateral C5 and C6 radicular involvement (the ventral root of spinal nerve) and left C4 radicular involvement were suspected. Since cervical magnetic resonance imaging showed no mechanical causality, cervical radiculopathy of unknown origin was suggested. Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) revealed increased FDG lineal uptake along the vessel walls, including the temporal arteries, vertebral arteries, axillary arteries, descending aorta, and femoral arteries (Fig. 2). Ultrasound examination showed absence of abnormality in the common carotid arteries, internal carotid arteries, and temporal arteries, but bilateral vertebral arteries were dilated to approximately 8 mm from bifurcation to C3 level (Fig. 3a and b). Ultrasound examination did not reveal any abnormality in the temporal artery. However, because 18F-FDG PET/CT revealed FDG uptake in the temporal arteries, a left superficial temporal artery biopsy was conducted that showed histopathological findings compatible with GCA (Fig. 4). Thirty milligrams (0.6 mg/kg) of oral prednisolone (PSL) was administered, and CRP test turned negative 10 days later. The patient could almost completely elevate both upper limbs almost immediately, his dyspnea on exertion disappeared, and he was discharged 20 days later. Currently, 4 years and 8 months after treatment, he is healthy and the result of CRP test remains negative with 1 mg of PSL (Fig. 1b) (Additional file 1).
Table 1
Laboratory data on admission
Complete blood cell
 White blood cell (/μL)
10,240
 Red blood cell (/μL)
3.4 × 106
 Hemoglobin (g/dL)
10.4
 Platelet (/μL)
79.5 × 104
Coagulation test
 APTT (second)
44.5
 PT-INR
1.28
Biochemistry
 HbA1c (%)
6.9
 BUN (mg/dL)
18.5
 Cr (mg/dL)
0.80
 eGFR (mL/minute/1.73 m2)
72.57
 Na (mEq/L)
137
 K (mEq/L)
5.1
Cl (mEq/L)
98
 AST (U/L)
78
 ALT (U/L)
68
 ALP (U/L)
568
 LDH (U/L)
359
 CK (U/L)
52
 T-Bil (mg/dL)
0.47
 TP (g/dL)
8.1
 Alb (g/dL)
2.3
 ESR (mm/hour)
31
Immunochemistry
 CRP (mg/dL)
13.99
 IgG (mg/dL)
2744
 ANA
< 40
 Anti-SS-A Ab (U/mL)
0.6
 RF (U/mL)
10.6
 ACPA (U/L)
0.5
 MMP-3 (ng/mL)
54.3
 C3 (mg/dL)
174.1
 C4 (mg/dL)
43.8
 CH50 (U/mL)
106.7
 MPO-ANCA (IU)
< 0.5
 PR3-ANCA (IU)
0.6
APTT, activated partial thromboplastin time; PT-INR, prothrombin time–international normalized ratio; HbA1c, hemoglobin A1c; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate; Na, sodium; K, potassium; Cl, chlorine; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; CK, creatine kinase; T-Bil, total bilirubin; TP, total protein; Alb, albumin; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; IgG, immunoglobulin G; ANA, antinuclear antibody; Anti-SS-A Ab, anti-SS-A antibody; RF, rheumatoid factor; ACPA, anti-cyclic citrullinated peptide antibody; MMP-3, matrix metalloproteinase-3; C3, complement component 3; C4, complement component 4; CH50, 50% hemolytic unit of complement; MPO-ANCA, myeloperoxidase-anti-neutrophil cytoplasmic antibody; PR3-ANCA, proteinase-3-anti-neutrophil cytoplasmic antibody
Table 2
Polymyalgia rheumatica classification criteria scoring algorithm—required criteria: age ≥ 50 years, bilateral shoulder aching, abnormal C-reactive protein level, and/or erythrocyte sedimentation rate
 
Points without US (0–6)
Points with US (0–8)
Morning stiffness duration > 45 minutes
2
2
Hip pain or limited range of motion
1
1
Absence of RF or ACPA
2
2
Absence of other joint involvements
1
1
At least one shoulder with subdeltoid bursitis and/or biceps tenosynovitis and/or glenohumeral synovitis (either posterior or axillary), and at least one hip with synovitis and/or trochanteric bursitis
NA
1
Both shoulders with subdeltoid bursitis, biceps tenosynovitis, or glenohumeral synovitis
NA
1
An individual with a score of ≥ 4 is categorized as having PMR in the algorithm without US, and an individual with a score of ≥ 5 is categorized as having PMR in the algorithm with US
PMR, polymyalgia rheumatica; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; US, ultrasonography; RF, rheumatoid factor; ACPA, anti-cyclic citrullinated peptide antibody; NA, not applicable
Table 3
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis
 
Score
Target population (who should be tested?): patients who
 
 1) have at least one joint with definite clinical synovitis (swelling)a
 
 2) have synovitis that is not attributable to another diseaseb
 Classification criteria for RA (score-based algorithm: add the scores in categories A–D; a score of ≥ 6/10 is needed for the classification of a patient as having definite RA)c
(A) Joint involvementd
 1 large jointe
0
 2−10 large joints
1
 1−3 small joints (with or without involvement of large joints)f
2
 4−10 small joints (with or without involvement of large joints)
3
 > 10 joints (at least one small joint)g
5
(B) Serology (at least one test result is needed for classification)h
 Negative RF and ACPA
0
 Low-positive RF or ACPA
2
 High-positive RF or ACPA
3
(C) Acute-phase reactants (at least one test result is needed for classification)i
 Normal CRP level and ESR
0
 Abnormal CRP level or normal ESR
1
(D) Duration of symptomsj
 < 6 weeks
0
 ≥ 6 weeks
1
aThe criteria are established for the classification of patients newly presenting with symptoms. In addition, patients with erosive disease typical of RA with a history compatible with prior fulfillment of the 2010 criteria should be classified as having RA. Patients with long-standing disease, including those whose disease is inactive (with or without treatment), and who, based on retrospectively available data, have previously fulfilled the 2010 criteria should be classified as having RA
bDifferential diagnoses differ in patients with different presentations but may include conditions such as systemic lupus erythematosus, psoriatic arthritis, and gout. If the relevant differential diagnoses to consider are unclear, an expert rheumatologist should be consulted
cAlthough patients with a score of < 6/10 are not classifiable as having RA, their status can be reassessed, and the criteria might be fulfilled cumulatively over time
dJoint involvement refers to any swollen or tender joint on examination, which may be confirmed by imaging evidence of synovitis. The distal interphalangeal, first carpometacarpal, and first metatarsophalangeal joints are excluded from the assessment. Categories of joint distribution are classified according to the location and number of involved joints, with placement into the highest category possible based on the pattern of joint involvement
e“Large joints” refers to the shoulders, elbows, hips, knees, and ankles
f“Small joints” refers to the metacarpophalangeal, proximal interphalangeal, second to fifth metatarsophalangeal, and thumb interphalangeal joints, as well as the wrists
gIn this category, at least one of the involved joints must be a small joint; the other joints can include any combination of large and additional small joints and other joints not specifically listed elsewhere (for example, temporomandibular, acromioclavicular, and sternoclavicular)
h“negative” refers to international unit values that are less than or equal to the upper limit of normal for the laboratory test and assay; “low-positive” refers to international unit values that are higher than the limit of normal but ≤ 3 times the limit of normal for the laboratory test and assay; and “high-positive” refers to international unit values that are more than three times the limit of normal for the laboratory test and assay. When RF information is only available as “positive” or “negative,” a “positive” result should be scored as “low-positive” for RF
iNormal/abnormal is determined on the basis of local laboratory standards
j“Duration of symptoms” refers to patients’ self-report of the duration of signs or symptoms of synovitis (for example, pain, swelling, and tenderness) of the joints that are clinically involved at the time of assessment, regardless of the treatment status
RA, rheumatoid arthritis; RF, rheumatoid factor; ACPA, anti-citrullinated protein antibody; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate
Table 4
Manual muscle test on admission
 
Right
Left
Dominant nerve
Biceps brachii
3/5
1/5
C5–C6
Triceps brachii
5/5
5/5
C6–C7–C8
Brachioradialis
5/5
1/5
C5–C6
Supinator teres
5/5
1/5
C5–C6
Pronator teres
5/5
5/5
C6–C7
Deltoid
3/5
1/5
C5–C6
Pectoralis major
3/5
3/5
C5–C6–C7–C8–T1
Trapezius
5/5
5/5
C3–C4
Supraspinatus
3/5
1/5
C5–C6
Infraspinatus
3/5
*
C5–C6
Rhomboids
5/5
5/5
C4–C5
Latissimus dorsi
5/5
5/5
C6–C7–C8
C, cervical; T, thoracic
*We could not assess the patient’s left infraspinatus muscle strength as he was unable to get the correct limb position

Discussion and conclusions

We reported a case of GCA with cervical radiculopathy presenting clinical symptoms similar to those of PMR or EORA.
PMR is an inflammatory disorder that occurs in elderly people older than 50 years. PMR is characterized by pain in both shoulders, neck, and hip girdle, and morning stiffness of more than 45 minutes. Moreover, nonspecific symptoms such as general fatigue and malaise may be observed. Elevated serum inflammatory markers are a typical feature [7, 9].
EORA is also an inflammatory disease that occurs in elderly people older than 60 years, and it is prevalent in men, has acute onset, involves the large and proximal joints, and has less RF positivity [10, 11]. In this case, although PMR and EORA were initially suspected because of old age, pain in both shoulders, difficulty in raising both upper limbs, and increased inflammatory response, the possibility of the incidence of these diseases was unlikely based on musculoskeletal ultrasound findings and each classification criteria. A precise neurological examination suggested cervical radiculopathy of unknown origin, and subsequent 18F-FDG PET/CT findings suggested GCA. The biopsy of the left superficial temporal artery confirmed the diagnosis of GCA.
Recently, a characteristic 18F-FDG PET/CT finding of PMR has been reported; FDG uptake was observed not only in the shoulder and hip joints but also in the ischial tuberosity, spinous process, and so on [9, 1214]. In this case, the lack of uptake of FDG in the ischial tuberosity and spinous process did not indicate PMR. Similarly, because FDG was not taken up in the joints at all, EORA could be ruled out.
As the mechanism of radiculopathy in GCA, vasculitis of the vertebral arteries could reduce blood flow in the radicular arteries, which supply blood to the spinal nerve roots [15]. Moreover, prior autopsy reports confirmed vasculitis in the radicular arteries rather than in the proximal feeding vessels [16].
In this case, radiculopathy occurred mainly in the C5 nerve as previously reported [5, 6]. The following mechanism has been proposed to explain C5 nerve dominance. The radicular arteries at the C1–C6 levels receive blood supply from the vertebral arteries, whereas the radicular arteries at the C7–T1 levels receive blood supply from the thyrocervical and costocervical trunks. Therefore, even if vertebral artery vasculitis occurs, the blood flow is relatively maintained at the C7–T1 levels, and radiculopathy is less likely to occur. The radicular arteries at the C1–C4 levels are also compensated by blood flow from the anterior spinal artery; hence, the C5 and C6 nerve roots are susceptible to radiculopathy [17].
It has also been reported that the muscles that control the C1–C3 nerves are located in the head and neck, and even if radiculopathy occurs in that area, it is difficult to establish a diagnosis [5]. Andrzejczak et al. reported the sources of vascularization of the brachial plexus using six autopsy cadavers. The vertebral and ascending cervical arteries were the most common sources of blood flow to the C5 and C6 nerve roots (both 35.29%). The subclavian artery predominantly supplied blood flow to the C7 nerve roots (66.67%) and the vertebral artery (8.33%). The deep cervical artery was the predominant source of blood flow to the C8 and T1 nerve roots (64.71%), but the vertebral artery is not a source of blood flow (0%). Therefore, C5 and C6 radiculopathy may be more likely to occur if vertebral artery vasculitis occurs; the blood vessels supplying the C1–C4 nerve roots are not described [18].
In this case, both upper limbs can be raised relatively immediately after treatment, and the treatment response is very similar to that of PMR. If radiculopathy occurs only due to ischemia as previously reported, the mechanism behind how both upper limbs can be elevated immediately after treatment remains unknown.
In this case, the vertebral arteries were among the affected blood vessels, and patient’s ultrasound revealed that the luminal diameter of bilateral vertebral arteries was dilated to approximately 8 mm before treatment and improved to approximately 5.5 mm 4 years and 8 months after treatment (Fig. 3). The luminal diameter of the vertebral artery was reported to be 3.6 ± 0.4 mm (mean ± SD) in healthy adults aged 60–85 years on ultrasound [19]. Anatomically, the vertebral arteries generally enter the transverse foramen at the C6 level and ascend, and the vertebral arteries and the cervical nerve roots are very close to each other at the C1–C6 levels. Therefore, the spread of inflammation of the vertebral artery can cause radiculopathy; once the inflammation improves after steroid treatment, the weakness in the upper limbs will also improve. However, this hypothesis is only speculative and needs to be evaluated in the future.
If this case was misdiagnosed as PMR or EORA based only on the clinical symptoms and laboratory data, the patient is expected to demonstrate CRP positivity, difficulty in raising both upper limbs, and dyspnea on exertion due to insufficient steroid treatment. If the patient continues to receive inadequate treatment, vascular complications may occur later. Therefore, it is essential to recognize that peripheral neuropathy of GCA can be manifested with radicular symptoms commonly affecting C5 nerve root. If the typical clinical symptoms of GCA are absent, then the clinical symptoms are similar to those of PMR or EORA. The musculoskeletal ultrasound and precise neurological examination were the turning points for the diagnosis of this case, and making a careful diagnosis using these methods was thought to be important.

Acknowledgements

The authors would like to thank Enago (www.​enago.​jp) for the English language review.

Declarations

This study has not been approved by the hospital committee to report this case report. However, the person in charge of the hospital verbally agreed. Written consent from the patient was obtained for participation.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Kawasaki A, Purvin V. Giant cell arteritis: an updated review. Acta Ophthalmol. 2009;87:13–32.CrossRef Kawasaki A, Purvin V. Giant cell arteritis: an updated review. Acta Ophthalmol. 2009;87:13–32.CrossRef
3.
Zurück zum Zitat Hollenhorst RW, Brown JR, Wagener HP, Shick RM. Neurologic aspects of temporal arteritis. Neurology. 1960;10:490–8.CrossRef Hollenhorst RW, Brown JR, Wagener HP, Shick RM. Neurologic aspects of temporal arteritis. Neurology. 1960;10:490–8.CrossRef
4.
Zurück zum Zitat Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology. 1988;38:685–9.CrossRef Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology. 1988;38:685–9.CrossRef
5.
Zurück zum Zitat Soubrier M, Dubost JJ, Tournadre A, Deffond D, Clavelou P, Ristori JM. Cervical radiculopathy as a manifestation of giant cell arteritis. Jt Bone Spine. 2002;69:316–8.CrossRef Soubrier M, Dubost JJ, Tournadre A, Deffond D, Clavelou P, Ristori JM. Cervical radiculopathy as a manifestation of giant cell arteritis. Jt Bone Spine. 2002;69:316–8.CrossRef
6.
Zurück zum Zitat Duval F, Lacoste I, Galli G, Chaumont H, Solé G, Léger F, et al. Acute brachial radiculoplexopathy and giant cell arteritis. Neurologist. 2018;23:23–8.CrossRef Duval F, Lacoste I, Galli G, Chaumont H, Solé G, Léger F, et al. Acute brachial radiculoplexopathy and giant cell arteritis. Neurologist. 2018;23:23–8.CrossRef
7.
Zurück zum Zitat Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64:943–54.CrossRef Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64:943–54.CrossRef
8.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.CrossRef Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.CrossRef
9.
Zurück zum Zitat González-Gay MA, Matteson EL, Castañeda S. Polymyalgia rheumatica. Lancet. 2017;390:1700–12.CrossRef González-Gay MA, Matteson EL, Castañeda S. Polymyalgia rheumatica. Lancet. 2017;390:1700–12.CrossRef
11.
Zurück zum Zitat Yazici Y, Paget SA. Elderly-onset rheumatoid arthritis. Rheum Dis Clin North Am. 2000;26:517–26.CrossRef Yazici Y, Paget SA. Elderly-onset rheumatoid arthritis. Rheum Dis Clin North Am. 2000;26:517–26.CrossRef
12.
Zurück zum Zitat Takahashi H, Yamashita H, Kubota K, Miyata Y, Okasaki M, Morooka M, et al. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Mod Rheumatol. 2015;25:546–51.CrossRef Takahashi H, Yamashita H, Kubota K, Miyata Y, Okasaki M, Morooka M, et al. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Mod Rheumatol. 2015;25:546–51.CrossRef
13.
Zurück zum Zitat Sondag M, Guillot X, Verhoeven F, Blagosklonov O, Prati C, Boulahdour H, et al. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Rheumatology. 2016;55:1452–7.CrossRef Sondag M, Guillot X, Verhoeven F, Blagosklonov O, Prati C, Boulahdour H, et al. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Rheumatology. 2016;55:1452–7.CrossRef
14.
Zurück zum Zitat Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology. 2007;46:672–7.CrossRef Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology. 2007;46:672–7.CrossRef
15.
Zurück zum Zitat Sänchez MC, Arenillas JI, Gutierrez DA, Gutierrez Alonso JL, Alvarez JD. Cervical radiculopathy: a rare symptom of giant cell arteritis. Arthritis Rheum. 1983;26:207–9.CrossRef Sänchez MC, Arenillas JI, Gutierrez DA, Gutierrez Alonso JL, Alvarez JD. Cervical radiculopathy: a rare symptom of giant cell arteritis. Arthritis Rheum. 1983;26:207–9.CrossRef
16.
Zurück zum Zitat Burton EA, Winer JB, Barber PC. Giant cell arteritis of the cervical radicular vessels presenting with diaphragmatic weakness. J Neurol Neurosurg Psychiatry. 1999;67:223–6.CrossRef Burton EA, Winer JB, Barber PC. Giant cell arteritis of the cervical radicular vessels presenting with diaphragmatic weakness. J Neurol Neurosurg Psychiatry. 1999;67:223–6.CrossRef
17.
Zurück zum Zitat Hughes TAT, Wiles CM, Hourihan M. Cervical radiculopathy and bilateral internuclear ophthalmoplegia caused by temporal arteritis. J Neurol Neurosurg Psychiatry. 1994;57:764–5.CrossRef Hughes TAT, Wiles CM, Hourihan M. Cervical radiculopathy and bilateral internuclear ophthalmoplegia caused by temporal arteritis. J Neurol Neurosurg Psychiatry. 1994;57:764–5.CrossRef
18.
Zurück zum Zitat Andrzejczak A, Kwolczak A, Ciszek B, Wojda-gradowska U. Brachial plexus vascularization—a preliminary study. Acta Clin. 2001;1:111–6. Andrzejczak A, Kwolczak A, Ciszek B, Wojda-gradowska U. Brachial plexus vascularization—a preliminary study. Acta Clin. 2001;1:111–6.
19.
Zurück zum Zitat Scheel P, Ruge C, Schöning M. Flow velocity and flow volume measurements in the extracranial carotid and vertebral arteries in healthy adults: reference data and the effects of age. Ultrasound Med Biol. 2000;26:1261–6.CrossRef Scheel P, Ruge C, Schöning M. Flow velocity and flow volume measurements in the extracranial carotid and vertebral arteries in healthy adults: reference data and the effects of age. Ultrasound Med Biol. 2000;26:1261–6.CrossRef
Metadaten
Titel
Giant cell arteritis with cervical radiculopathy mimicking polymyalgia rheumatica and elderly-onset rheumatoid arthritis: a case report
verfasst von
Akihiko Nakabayashi
Hiroki Ikai
Yoshinori Katada
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Journal of Medical Case Reports / Ausgabe 1/2021
Elektronische ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-03107-7

Weitere Artikel der Ausgabe 1/2021

Journal of Medical Case Reports 1/2021 Zur Ausgabe